Crohn Disease Clinical Trial
Official title:
Improving OutcoMes in the Pediatric to Adult Care Transition in Inflammatory Bowel Disease
The transition from pediatric to adult IBD care can be stressful and wrought with challenges including access to care and establishment of new physician-patient relationships. There a few studies which characterize patterns of healthcare utilization during this critical period and its impact on outcomes. We hypothesize that uninterrupted healthcare utilization in academic centers and optimized communication with patients during the pediatric-adult transition period is associated with lower hospitalizations and surgery. This hypothesis will be addressed by a randomized clinical trial to determine the impact of monthly regular telephone contact with an IBD Registered Nurse versus standard of care during the pediatric-adult transition period. Outcomes will include healthcare utilization, health-related quality of life, patient satisfaction, and treatment adherence over 12 months of follow-up. Randomization and analyses will be stratified by whether subjects were transferred to adult care in an academic center or in a community practice. We hope that this research will facilitate optimal delivery of healthcare during the pediatric-adult transition.
Rationale: The years marking the transition from pediatric-to-adult transition can be
particularly difficult and transitioning patients with IBD may be at increased risk for loss
to follow-up. As patient advocates, we need an intervention that would enable continuity of
care especially among young adults who may face obstacles in accessing regular office visits.
An intervention such as regular email contact with an IBD nurse may especially benefit those
who are transitioning to community gastroenterology practices or to geographic regions where
there is difficulty in accessing gastroenterology care. The lack of continuity of care may
lead to delayed treatment which may be associated with poor clinical outcomes.
Research Question and Hypothesis: Our primary question is whether regular email contact with
an IBD nurse can improve health outcomes. We hypothesize that such interaction, through
augmented continuity of care will lead to increased patient satisfaction, increased medical
adherence, improved transition readiness, decreased disease activity, and consequently
decreased costly visits to the emergency department and hospitalizations.
Study Design: Multi-center randomized controlled clinical trial
Study population and inclusion/exclusion criteria: This study comprise adolescent subjects
recruited from the IBD clinics of the Hospital for Sick Children, McMaster Children's
Hospital or Children's Hospital of Eastern Ontario who meet the following inclusion criteria:
(1) diagnosis of IBD; (2) at least age 16 years or older; (3) planning to undergo transition
of care and will be followed by a gastroenterologist in either an academic center or the
community; (4) have access to email or other means of telecommunication. We will exclude any
subjects who will not be residing in Canada or who will not be enrolled in the Ontario Health
Insurance Plan after exiting pediatric care. Registration with OHIP, even if residing in a
different province, is required for monitoring of health utilization.
Health Implications: Our study may demonstrate cost-savings from decreased non-routine
healthcare utilization coupled with improvement in health outcomes that may support the more
widespread use of routine email-based interactions with IBD allied health providers in the
pediatric-adult transition period.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04046913 -
The ADDapt Diet in Reducing Crohn's Disease Inflammation
|
N/A | |
Recruiting |
NCT05169593 -
Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biological Therapy
|
Phase 4 | |
Recruiting |
NCT06116604 -
Early Bowel Resection for Terminal Ileal Crohn's Disease
|
||
Recruiting |
NCT05316584 -
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy
|
N/A | |
Recruiting |
NCT05627128 -
A Culturally Tailored Dietary Intervention to Treat Crohn's Disease
|
N/A | |
Recruiting |
NCT05294107 -
Intestinal Organoids
|
N/A | |
Withdrawn |
NCT04349449 -
ENTYVIO in Bio-naive Patients With Moderate/Severe Crohn's Disease (CD) in Daily Practice
|
||
Completed |
NCT05051943 -
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
|
||
Completed |
NCT03058679 -
Trial of Specific Carbohydrate and Mediterranean Diets to Induce Remission of Crohn's Disease
|
N/A | |
Completed |
NCT02871635 -
BI 695501 Versus Humira in Patients With Active Crohn's Disease: a Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity
|
Phase 3 | |
Recruiting |
NCT04266600 -
Extended Mesenteric Excision in Ileocolic Resections for Crohn's Disease
|
N/A | |
Recruiting |
NCT04539665 -
Extended Mesenteric Excision in Ileocolic Resections for Crohn's Disease.
|
N/A | |
Recruiting |
NCT03913572 -
Treatment of Perianal Disease Using Adipose-derived Stem Cells
|
||
Completed |
NCT03606499 -
Real-world Effectiveness of Ustekinumab in Participants Suffering From Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) With Extra-intestinal Manifestations or Immune-mediated Inflammatory Diseases
|
||
Completed |
NCT03668249 -
A Study to Characterize Multidimensional Model to Predict the Course of Crohn's Disease (CD)
|
||
Terminated |
NCT04102111 -
A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease
|
Phase 2 | |
Recruiting |
NCT04997733 -
Fecal Microbiota Transplantation in Crohn's Disease as Relay After Anti-TNF Withdrawal
|
Phase 3 | |
Recruiting |
NCT05906576 -
Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients
|
Phase 4 | |
Not yet recruiting |
NCT04398836 -
Preoperative Nutrition for Crohn's Disease Patients
|
Phase 3 | |
Not yet recruiting |
NCT04502303 -
18F-FDG and 68Ga-FAPI PET/CT in Crohn's Disease
|
Phase 2 |